HERTHENA-Lung02

Developer: Medable Inc.

Category: Medical

Add App to Comparison

171 installs

Ratings not yet available

15 monthly active users

Revenue not available

Install Trends

Weekly +5.00

Trending

Monthly +21

Trending

HERTHENA-Lung02 Summary

HERTHENA-Lung02 is a mobile Android app in Medical by Medable Inc.. Released in Apr 2022 (3 years ago). It has about 171+ installs Based on AppGoblin estimates, it reaches roughly 15 monthly active users . Store metadata: updated Feb 10, 2025.

Recent activity: 5.00 installs this week (21 over 4 weeks) showing exceptional growth View trends →

Store info: Last updated on Google Play on Feb 10, 2025 .

SDKs, Trackers & Permissions

App not yet scanned for SDKs.

App Details

Store ID: com.medable.syneos.u31402au301

First Released: 2022-04-26

Store Last Updated: 2025-02-10

In-App Purchases: No

Ads: No

App Store

Crawl Status: Success

AppGoblin First Crawled: 2024-11-30

AppGoblin Last Crawled: 2026-04-14

Ads & App-Ads.txt

App does not have ads.

AppGoblin SDK Scans

App not yet analyzed for SDKs.

The download and scan process is automated but can require manual troubleshooting. Feel free to reach out if your request does not complete in 24hrs or if you have any questions.

0★

Ratings: 0

5★

4★

3★

2★

1★

Screenshots

App Description

Solely intended for participants in the Daiichi Sankyo HERTHENA Lung02 study

This app has been exclusively created for participants in the medical study for Daiichi Sankyo HERTHENA–Lung02. It contains Televisit functionality and allows participants to complete questionnaires.

The Daiichi Sankyo HERTHENA–Lung02 study is a Phase 3, randomized, open-label study of Patritumab Deruxtecan versus platinum-based chemotherapy in metastatic or locally advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) after failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) therapy